Evaxion will provide company and scientific updates at conferences in both the US and Europe during the coming weeks and months COPENHAGEN, Denmark, March 4, 2
Originally planned as a two-year study, the trial has been extended by an additional year to collect three-year clinical outcome data The additional third year
Shares of Palantir Technologies Inc. PLTR rose sharply in today's pre-market trading following better-than-expected fourth-quarter results.
Palantir reported f...
Shares of Twilio Inc. TWLO rose sharply in today's pre-market trading after the company provided preliminary financial results for the fourth quarter.
After th...
Trial remains on track for completion and data readout in the second half of 2025 COPENHAGEN, Denmark, January 15, 2025 - Evaxion Biotech A/S ( EVAX) (”Evaxi
COPENHAGEN, Denmark, January 14, 2025 - Evaxion Biotech A/S ( EVAX) (”Evaxion” or the ”Company”), a clinical-stage TechBio company specializing in devel
COPENHAGEN, Denmark, January 10, 2025 - Evaxion Biotech A/S ( EVAX) (”Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunologyâ„
COPENHAGEN, Denmark, December 30, 2024 - Evaxion Biotech A/S ( EVAX) (”Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunologyâ
Editor’s note: This story has been corrected to state that Castellum Inc — not Constellium SE — announced the pricing of a public stock offering.
With U....
With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Constellium SE CSTM announc...
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.
Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, but issued FY24 EPS guidance below estimates.